Study:
A Prospective Cohort Study to Describe the Evolution of Persistent Hyperparathyroidism in Kidney Transplant Recipients
Rationale:
n/a
Purpose:
The purpose of this study is to see if Hyperparathyroidism (HPT) is common in people who
receive a kidney transplant. Patients with HPT often have high parathyroid hormone (PTH)
levels and may have large parathyroid glands in the neck. Patients with HPT can develop bone
disease (osteodystrophy). This bone disease can cause bone pain, fractures, and poor
formation of red blood cells. Other problems from HPT may include increases in blood levels
of calcium (hypercalcemia) and low blood levels of phosphorus (hypophosphatemia). The high
calcium levels may cause calcium to deposit in body tissues. Calcium deposits can cause
arthritis (joint pain and swelling), muscle inflammation, itching, gangrene (death of soft
tissue), heart and lung problems, or kidney transplant dysfunction (worsening of kidney
transplant function). The purpose of this research study is to better understand the
evolution of Hpt in people during the first 12 months after receiving a kidney transplant.
Study Status: Enrolling by invitation
Recruiting:
n/a
| Condition |
Intervention |
Phase |
|
Hyperparathyroidism |
n/a |
N/A |
Verified by
The Cleveland Clinic
January, 2012
Sponsored by: The Cleveland Clinic
Information provided by: The Cleveland Clinic
ClinicalTrials.gov identifier: NCT01163669
Study Type: Interventional
Study Design: Observational Model: Cohort, Time Perspective: Prospective
Cleveland Clinic
Cleveland, Ohio 44195
United States
T Srinivas, MD, MD., Principal Investigator